Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update
- 15 February 1994
- Vol. 73 (4) , 1134-1142
- https://doi.org/10.1002/1097-0142(19940215)73:4<1134::aid-cncr2820730403>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Intra-arterial Floxuridine vs Systemic Fluorouracil for Hepatic Metastases From Colorectal CancerArchives of Surgery, 1990
- Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinomaCancer, 1990
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvementCancer, 1989
- A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver MetastasesAnnals of Surgery, 1987
- Intrahepatic or Systemic Infusion of Fluorodeoxyuridine in Patients with Liver Metastases from Colorectal CarcinomaAnnals of Internal Medicine, 1987
- Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primariesCancer, 1986
- Reporting results of cancer treatmentCancer, 1981
- Mechanism of cytotoxicity of 5-fluorouracil: Distinction between the irreversible cytotoxic effect of 5-fluorouridine and the reversible cytotoxic effect of 5-fluoro-2?-deoxyuridine on murine lymphoma L5178Y cells in cultureZeitschrift für Krebsforschung und Klinische Onkologie, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958